BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 238 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $57,763,218 | -34.9% | 9,346,799 | -46.5% | 0.00% | -25.0% |
Q1 2024 | $88,784,908 | +16.0% | 17,477,344 | +36.8% | 0.00% | 0.0% |
Q4 2023 | $76,534,248 | +3.3% | 12,777,003 | +22.1% | 0.00% | 0.0% |
Q3 2023 | $74,101,956 | -14.2% | 10,466,378 | -14.7% | 0.00% | -20.0% |
Q2 2023 | $86,338,342 | -9.1% | 12,263,969 | +7.7% | 0.01% | 0.0% |
Q1 2023 | $94,989,576 | -62.8% | 11,389,623 | -48.8% | 0.01% | -37.5% |
Q4 2022 | $255,472,728 | +115.6% | 22,253,722 | +136.6% | 0.01% | +14.3% |
Q3 2022 | $118,494,000 | +1.8% | 9,404,247 | -14.5% | 0.01% | 0.0% |
Q2 2022 | $116,431,000 | -4.0% | 11,004,803 | +47.5% | 0.01% | +16.7% |
Q1 2022 | $121,344,000 | +6.2% | 7,462,752 | -9.5% | 0.01% | +20.0% |
Q4 2021 | $114,249,000 | +11.9% | 8,249,029 | +16.1% | 0.01% | 0.0% |
Q3 2021 | $102,103,000 | +3.3% | 7,105,323 | +13.6% | 0.01% | 0.0% |
Q2 2021 | $98,856,000 | +33.0% | 6,252,772 | -14.4% | 0.01% | +25.0% |
Q1 2021 | $74,331,000 | -9.8% | 7,308,816 | -33.9% | 0.00% | -20.0% |
Q4 2020 | $82,374,000 | +48.2% | 11,056,979 | -31.7% | 0.01% | +25.0% |
Q3 2020 | $55,592,000 | -25.1% | 16,183,973 | +3.9% | 0.00% | -20.0% |
Q2 2020 | $74,231,000 | +545.9% | 15,578,395 | +171.1% | 0.01% | +400.0% |
Q1 2020 | $11,492,000 | -39.4% | 5,746,052 | +4.6% | 0.00% | 0.0% |
Q4 2019 | $18,951,000 | +36.1% | 5,492,943 | +13.0% | 0.00% | 0.0% |
Q3 2019 | $13,929,000 | -44.7% | 4,861,776 | -26.8% | 0.00% | -50.0% |
Q2 2019 | $25,187,000 | -11.8% | 6,645,717 | +89.3% | 0.00% | 0.0% |
Q1 2019 | $28,572,000 | +26.6% | 3,510,042 | +25.5% | 0.00% | 0.0% |
Q4 2018 | $22,571,000 | -12.9% | 2,796,960 | -17.6% | 0.00% | 0.0% |
Q3 2018 | $25,909,000 | +23.0% | 3,395,701 | -7.7% | 0.00% | 0.0% |
Q2 2018 | $21,072,000 | -2.0% | 3,677,404 | -18.4% | 0.00% | 0.0% |
Q1 2018 | $21,494,000 | +12.4% | 4,504,714 | +15.7% | 0.00% | 0.0% |
Q4 2017 | $19,120,000 | +23.0% | 3,894,547 | +31.2% | 0.00% | +100.0% |
Q3 2017 | $15,545,000 | -28.5% | 2,967,585 | -24.1% | 0.00% | -50.0% |
Q2 2017 | $21,736,000 | +13.9% | 3,909,013 | +72.0% | 0.00% | 0.0% |
Q1 2017 | $19,083,000 | +44.1% | 2,272,104 | +8.6% | 0.00% | +100.0% |
Q4 2016 | $13,246,000 | +122.8% | 2,092,888 | +55.2% | 0.00% | 0.0% |
Q3 2016 | $5,945,000 | +56.3% | 1,348,308 | +0.7% | 0.00% | – |
Q2 2016 | $3,803,000 | +0.0% | 1,339,348 | -0.3% | 0.00% | – |
Q1 2016 | $3,802,000 | -82.6% | 1,343,332 | -36.5% | 0.00% | -100.0% |
Q4 2015 | $21,823,000 | -39.3% | 2,114,768 | -32.9% | 0.00% | -50.0% |
Q3 2015 | $35,938,000 | -25.0% | 3,152,313 | -1.8% | 0.00% | -20.0% |
Q2 2015 | $47,927,000 | +58.9% | 3,210,208 | -3.9% | 0.01% | +66.7% |
Q1 2015 | $30,171,000 | -11.1% | 3,341,212 | +19.7% | 0.00% | 0.0% |
Q4 2014 | $33,933,000 | +48.8% | 2,790,435 | +19.7% | 0.00% | +50.0% |
Q3 2014 | $22,811,000 | -20.4% | 2,332,066 | +3.8% | 0.00% | -33.3% |
Q2 2014 | $28,653,000 | +65.3% | 2,247,454 | +37.2% | 0.00% | +50.0% |
Q1 2014 | $17,334,000 | +1124.2% | 1,638,419 | +121.2% | 0.00% | – |
Q4 2013 | $1,416,000 | +296.6% | 740,687 | +1412.1% | 0.00% | – |
Q3 2013 | $357,000 | +457.8% | 48,984 | +18.7% | 0.00% | – |
Q2 2013 | $64,000 | – | 41,284 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |